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Introduction: NICE recommends that the majority of women
should be offered immediate breast reconstruction with its
potential to improve health related quality of life (HRQL). There
is conflicting evidence with a lack of ‘hard’data to best inform cli-
nicians and their patients. Our aim was to evaluate the effects of
implant-assisted LD (LDI) versus autologous LD (ALD) breast
reconstruction on HRQL over 12 months.
Methods: A prospective longitudinal multicentre study com-
menced in early 2007. Patient reported outcome measures using
the EORTC C30 (general HRQL), BR-23 (breast + arm symptoms),
Body Image Scale (BIS) and HADS, were completed pre-operatively
and at 3, and 12 months after surgery. Longitudinal analyses tested
the effects of treatment variables, baseline HRQL, age and time on
QL domains (3–12 months). Significance was set at p = 0.01.
Results: One hundred and seventy one patients (93 ALD, 78 LDI)
were recruited. There were no significant differences in HRQL
domains between LDI and ALD (±RT). Chemotherapy patients
reported poorer overall HRQL (p < 0.001), poorer role (p = 0.003)
and social (p = 0.01) functioning, and greater fatigue (p = 0.002)
and depression (p = 0.01). Older patients had fewer HRQL issues
(p = 0.01). Significant improvements over time were seen for over-
all HRQL and other domains (p < 0.001). There were no significant
differences between LDI and ALD for patient satisfaction with
surgical outcome. Good satisfaction with overall breast appear-
ance and surgical outcome was significantly associated with
fewer body image concerns.
Conclusion: There is an important need for cumulative clinical
evidence in this field on which to base patient informed consent
and clinical recommendations.
doi:10.1016/j.ejcsup.2010.06.093
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Introduction: Breast reconstruction (BR) aims to recreate the
appearance of the missing breast as well as restoring body image.
To date, studies have used a range of questionnaires relating to
general health, breast cancer, body image or are study-specific.
Currently there is no validated breast reconstruction-specific
questionnaire that assesses the relative impact of the different
reconstruction techniques on both cosmetic and related quality
of life (QL) outcomes.
Methods: Phases I and II of the design of the questionnaire fol-
lowed the EORTC guidelines which consisted of a systematic liter-
ature review to identify relevant ‘issues’. Patients who had
received breast reconstructions plus Healthcare professionals
were interviewed and asked which ‘issues’ they also felt were
important
Results: The literature search and interviews yielded 69 issues
relating to BR and QL. Eighty-nine patients, and 9 Healthcare pro-
fessionals, including breast surgeons, psycho-oncologists and
breast care nurses were interviewed from Sweden, Italy and the
UK. These issues were formed into potential questions for the
module. The resulting module (EORTC QLQ- BrR31) consists of
31 questions ordered in appropriate scales of: body image, sexual-
ity, and cosmetic outcome of the reconstruction, the donor site
and the nipple including treatment or surgery related symptoms,
e.g. pain.
Conclusions: A protocol based questionnaire development pro-
cess has been used to provide a new measure of BR which can
now proceed to phase III testing in over 200 women from 5 Euro-
pean countries and will also be used in the first UK multicentre
randomised trial in BR (QUEST).
doi:10.1016/j.ejcsup.2010.06.094
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Introduction: Outcome measures of breast reconstruction
include oncological safety, aesthetics and function. Patient satis-
faction with their breast reconstruction is a ‘holistic’ entity that
must be distinguished from aesthetic, photographic and profes-
sional satisfaction; it is not easily quantifiable.
Patients and methods: 131 women with a latissimus dorsi (Lat
Dorsi) pedicled reconstruction between 1996 and 2008 were sent
a questionnaire.
70% had immediate reconstruction.
88% had an implant assisted procedure.
29% had bilateral surgery.
40% had post operative chest wall radiotherapy.
Results: 86 women returned a completed questionnaire: 66%
response rate.
Aesthetics of breast reconstruction; Good
 80% patients would rate their overall Breast Reconstruction
7/10 and above.
 Satisfaction of surgery with bra – 77.8% – Excellent/ good.
 Satisfaction of surgery without bra – 47.6% – Excellent/good.
 Symmetry of surgery with normal breast – 45.2% – Excellent/
good.
 95.3% patients would recommend Breast Reconstruction
surgery.
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Functionality of breast reconstruction; Less good
 Reduced mobility – 50%
 Firmer consistency – 59.3%
Effects of radiotherapy
 Overall rating with R/T (7/10 and above) 80%; without R/T
81%
Conclusions: Patient reported outcomes after post mastectomy
Lat Dorsi breast reconstruction are acceptable; aesthetics have
not been objectively assessed but subjectively are reasonable.
Highlighted is that this type of reconstruction results in a func-
tionally inferior breast compared to the contra-lateral normal
side.
Unexpectedly, patient reported outcomes after radiotherapy
were no worse; this may reflect an increased ‘preparedness’ for
a worse outcome from adequate pre-operative information.
doi:10.1016/j.ejcsup.2010.06.095
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The aim of the study was to determine whether and to what
extent mindfulness-based stress reduction (MBSR) has any effect
on mood, disease related quality of life, wellbeing and endocrine
symptoms in women with stages 0–III breast cancer.
The study chiefly used a randomised controlled trial design.
Eligible participants had previously attended a day centre, Breast
Cancer Haven in London, which offers support, information and
complementary therapies for women. Eligibility was based on
ending hospital treatment for breast cancer no less than
2 months and no more than 2 years previously (N = 229). Consent-
ing participants were randomly assigned to either an immediate
intervention or wait-list control group. Participants completed
the Profile of Mood States (POMS) (primary outcome measure),
Functional Assessment of Cancer Therapy-Breast (FACT-B) and -
Endocrine (FACT-ES), including their trial outcome indices (TOI)
and World Health Organisation Five-Item Wellbeing Question-
naire (WHO-5) as well as a short proforma to obtain qualitative
data.
Two hundred and fourteen women (mean age 49 years) com-
pleted the study, (a 93% response rate). Intention-to-treat
between-group analysis showed that after the intervention, par-
ticipants in the MBSR group, compared to controls, had statisti-
cally significantly improved scores on POMS Total Mood
Disturbance at both eight weeks with MBSR group mean (SD) of
30.02 (31.60) compared to controls 47.81(39.81) (95% CI for differ-
ence 27.44 to 18.14, p < 0.001) and 12 weeks mean (SD) of
29.83 (34.19) compared to controls 45.43 (35.51) (95% CI 25.01 to
6.20, p < 0.001). Significant improvements were also found on
all POMS subscales – anxiety, depression, anger, vigour, fatigue
and confusion. Significant improvements were also found on a
range of FACT dimensions: FACT-B, -ES, -B TOI, -ES TOI, and phys-
ical, emotional and functional wellbeing subscales, as well as on
the WHO-5 Wellbeing Questionnaire. Qualitative findings
revealed that participants found themselves to be more mindful
and key themes included being calmer, centred, at peace, con-
nected and more confident; being more aware; coping with stress,
anxiety and panic; and accepting things as they are, being less
judgemental of myself and others.
MBSR was effective in improving mood state, quality of life
including endocrine symptom and wellbeing in female breast
cancer survivors (diagnosed with stages 0–III breast cancer).
doi:10.1016/j.ejcsup.2010.06.096
O-96 USING A NEEDS ASSESSMENT TOOL IN BREAST CANCER
FOLLOW-UP
Susanne Cruickshank, D.M. Barber, C. Kennedy, A. Rowat, R.
Small. Edinburgh Napier University, UK
Introduction: Needs which arise for women with breast cancer
are complex and are directly influenced by their individual expe-
rience from diagnosis, through treatment and beyond. The aim of
this study is to assess the effectiveness of using a needs assess-
ment tool during a clinical consultation.
Research questions:
1. To identify the perceived needs of breast cancer patients
attending follow-up clinics.
2. To examine the relationship between the measures of per-
ceived need, quality of life and satisfaction with care.
3. To investigate the differences between those receiving the
standard follow-up care and those receiving care by SBCN
using the needs assessment tool on measures of patients sat-
isfaction with care, perceived needs and quality of life.
Method: A prospective randomised controlled trial. Women are
randomised into two groups: group 1 receives the usual follow-up
care by the clinician and group 2 receives follow-up care by the
Specialist Breast Care Nurse (SBCN), who uses the needs identi-
fied by the woman in the tool, to guide the consultation and sub-
sequent interventions.
Summary of results: Ninety-two women have been recruited
who are up to five years since diagnosis. A wide range of needs
were reported including pain/discomfort in affected breast, fears
of cancer returning and changes in sexuality/relationships. This
presentation will report the descriptive demographic and clinical
characteristics of participants along with comparative data
between the groups.
Conclusion: The findings indicate that new methods of eliciting
the needs of women during the follow-up consultation are neces-
sary to offer women appropriate and timely interventions.
doi:10.1016/j.ejcsup.2010.06.097
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